சோதனைகள் தொடங்கியது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from சோதனைகள் தொடங்கியது. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In சோதனைகள் தொடங்கியது Today - Breaking & Trending Today

Global Molecular Diagnostics for Cancer Markets Report 2021-2025: Companion Diagnostics and Liquid Biopsy Drive Market Growth while Lowering Costs; COVID-19 Causes Resources Shift


7 Molecular Diagnostics Recent Developments
7.1 Recent Developments - Importance and How to Use This Section
7.1.1 Importance of These Developments
7.1.2 How to Use This Section
7.2 Nucleix to Invest in Early-Stage Lung Cancer Dx
7.3 Invitae to Acquire Genosity for $200M
7.4 Bio-Techne Obtains CE Mark for Exosomal Liquid Biopsy Prostate Test
7.5 Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience
7.6 Natera Revenues Grow 35 Percent
7.7 AnchorDx Closes $40M Financing Round
7.8 Exact Sciences Strategy for End-to-End Cancer Testing
7.9 Genomics England: Whole Genome Sequencing for Cancer Patients to Launch
7.10 Singlera Genomics Closes $150M Funding for Cancer Screening
7.11 Biocartis GeneproDx, Endpoint Health Collaborate on Tests for Idylla Platform ....

United States , New York , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Biocartis Geneprodx , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Sciences Strategy For Cancer Testing , Technology Development , Us Medicare Expenditures For Laboratory Testing , Singlera Genomics Inc , Physician Lab , Mdx Clinical Laboratory , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc ,

Global Cancer Molecular Diagnostics Markets 2021-2025 - New Diagnostics Create New Markets


A market with fundamental growth factors is impacted by the COVID-19 Pandemic.
Molecular Diagnostics for Cancer is positioned to directly benefit from the explosion in genomics knowledge but shifting resources to deal with the COVID emergency may interrupt growth. Learn all about it in this new report. the publisher includes a special segment, Cancer Companion Diagnostics, a new segment of the market that is reshaping the industry. And now over 130 companies are profiled. A range of dynamic trends are pushing market growth and company valuations.
Working against this dynamic market are the forces of the COVID Driven Recession. The publisher s latest numbers factor in the different COVID forces, their timing, and their effect on growth. ....

New York , United States , Miltenyi Biotec , Yourgene Elucigene , Qiagen Gmbh , Sysmex Inostics , Bristol Myers Squibb , Siemens Healthineers , Laura Wood , Academic Research Lab , Testing Lab , Mdx Companion Dx Development , Public National , Technology Development , Us Medicare Expenditures For Laboratory Testing , Physician Lab , Physician Office Lab , Servier Sign Liquid Biopsy Services Deal , Enzo Life Sciences Inc , Office Hours Call , Biodesix Inc , Datar Cancer Genetics , Fluidigm Corp , Accuragen Inc , Business Development Staff , Genefirst Ltd ,

Global Cell Based Assay & High Content Screening Markets Report 2021-2025: 3D Assays, Automation, Software, Primary Cells, Signalling and Reporter Genes, The Next Five Years


4.3.6 The Next Five Years
5. Cell Based Assays Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Axxam and FUJIFILM Cellular Dynamics Announce Strategic Alliance
Cancer Genetics to Acquire Organoid Startup Stemonix
Curi Bio Acquires Artificial Intelligence Firm Dana Solutions
CRISPR Screens Uncover Novel Cancer Therapy Targets
ERS Genomics Licenses CRISPR-Cas9 Patents to Axxam
New Transcriptomics Assay Facilitates Compound Screens
Carta Biosciences Betting on Gene Interaction Mapping
High-throughput Identifies cancer drug candidates
Velabs Therapeutics partners with Alytas Therapeutics to develop a novel immune-based therapy for obesity
InSphero platform selected to test Cyclerion s sGC stimulator technology ....

Leica Biosystems , Miltenyi Biotec , Cisbio Bioassays , Qiagen Gmbh , Excellerate Bioscience , Laura Wood , Academic Research Lab , Cell Biolabs Inc , Contract Research Organization , Cell Signaling Technology Inc , Biovision Inc , Technology Development , Profiles Of Key Cell Based Assay Companies , Merck Co Inc , Technology Convergence , Enzo Life Sciences Inc , Office Hours Call , Pharmceutical Research Spending , Design Development , Corning Inc , Thermo Fisher Scientific Inc , Cellular Dynamics Announce Strategic Alliance , Lonza Group Ltd , Pharmaceutical Company , Reaction Biology Corporation Purchases Proqinase Gmb , Screening Service ,

Global Immuno-Oncology Diagnostics Markets, 2021-2025: Checkpoint Assays, Cytokine Assays, Genomic Germline, Genomic Tumour, Tumor Microenviroment


4.3.2 Shifting Role of Diagnostics
4.3.3 Multiplexing and Foundation One
4.3.4 The Disruption Dynamic
4.3.6 The Next Five Years
5. Cancer Immuno-Oncology Diagnostics Recent Developments
5.1 Recent Developments - Importance and How to Use This Section
5.1.1 Importance of These Developments
5.1.2 How to Use This Section
Qiagen Expands Immuno-Oncology Portfolio
IncellDx Awarded PD-L1 Detection Patent
FDA Approves CDx for Trastuzumab
Promega Nabs CE Mark for Microsatellite Instability IVD
ArcherDx partners with AstraZeneca for Immuno-Oncology
Germline Results Guides Precision Therapy
Agilent PD-L1 Assay Gets FDA Approval
Bayer, OrigiMed Form Companion Diagnostic Development Alliance
Bio-Me to Develop Microbiome Biomarker Test for Cancer Immunotherapy
SkylineDx, BioInvent Collaborate to Characterize Predictive Immunological ....

Agena Bioscience , Nugenerex Immuno , Dako Agilent , Clearbridge Biomedics , Bristol Myers Squibb , Leica Biosystems , Laura Wood , Foundation Medicine , Academic Research Lab , Guardant Health , Testing Lab , Public National , Technology Development , Thermo Fisher , Origimed Form Companion Diagnostic Development Alliance , Merck Co Inc , Cytolumina Technologies Corp , Physician Lab , Beckman Coulter , Epic Sciences , Mdx Health , Custom Research , Genomic Health , Office Hours Call , Becton Dickinson , Biodesix Inc ,